Director · CAPRICOR THERAPEUTICS, INC. · CAPRICOR THERAPEUTICS, INC. — Stock Option (Right to Buy)
Side
A
Value
—
Shares
1,360
Price
—
Executed
Jan 5, 2026
Disclosed
Jan 7, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Jan 5 executedJan 7, 2026 disclosed
CAPR · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
CAPRICOR THERAPEUTICS, INC. — Stock Option (Right to Buy)
Ticker
CAPR
Shares
1,360
Price per share
$0
Execution date (reported)
Jan 5, 2026
Owned after transaction
1,360 shares
Days from execution to publication
2
What this establishes
Auwaerter Paul Gisbert filed this Form 4 reporting a grant or award of CAPR on Jan 5, 2026. It became public on Jan 7, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director
Auwaerter Paul Gisbertcik:0001982730
Issuer
CAPRICOR THERAPEUTICS, INC.cik:0001133869
Revision history · 0
No field has changed since this record was first ingested.
